Tag
HealthCare Global Enterprises Limited
9 articles
HealthCare Global Enterprises Limited is strategically expanding its oncology services and bolstering its financial position. The company reported a robust 15% revenue increase to ₹25.5 billion for fiscal year 2026, alongside a 19% rise in adjusted EBITDA, demonstrating margin improvement. To fuel further growth, HCG completed a ₹4,250 million rights issue and is divesting its non-core fertility healthcare business, BACC Health Care, for ₹37.64 crore, allowing for capital reallocation to cancer care. Furthermore, the launch of a new 132-bed hospital in Bengaluru, equipped with advanced technology like the Elekta Unity MR-Linac, signals a significant expansion of HCG’s capacity and capabilities within the oncology landscape.
HCG Posts March 2026 Earnings Call Recording
HealthCare Global Enterprises Ltd made its Q4 FY26 earnings call audio recording available on its investor relations website.
The call was held on May 20, 2026, to discuss audited standalone and conso
HCG Reports No Rights Issue Fund Deviation Q4 FY26
HealthCare Global confirms no deviation in use of ₹424.68 crore Rights Issue proceeds for quarter ended March 31, 2026.
Funds were raised for debt repayment, subsidiary stake acquisition, and general
HCG Divests BACC HealthCare for INR 37.64 Crore
HealthCare Global Enterprises Limited executed a Share Purchase Agreement to divest its entire equity stake in BACC Health Care Private Limited to Inviga Healthcare Fund I for INR 37.64 crore.
BACC co
HCG FY26 Revenue Up 15% to ₹25.5B
HCG announced Q4 and FY26 results with 15% YoY revenue growth to ₹25,454 million for the full year.
Adjusted EBITDA grew 19% to ₹4,711 million with margins expanding to 18.5% for FY26.
The company com
HCG Q4 Revenue Up 11% YoY, FY26 Growth at 15%
HCG reported Q4FY26 revenue of INR 6,523 Mn, up 11% YoY, and FY26 revenue of INR 25,454 Mn, up 15% YoY.
Adjusted EBITDA for FY26 stood at INR 4,711 Mn, up 19% YoY, with margin expansion of 68 bps to 1
HCG Board Approves Key Management Appointments
HCG Board re-appoints Rajiv Maliwal as Independent Director for a second five-year term effective May 25, 2026.
Sanjeev Kumar appointed as new Chief Financial Officer effective May 25, 2026, replacing
HCG Divests BACC Health Care for INR 37.64 Crore
HealthCare Global Enterprises Limited Board approved divestment of entire equity stake in BACC Health Care Private Limited to Inviga Healthcare Fund I for INR 37.64 crore.
Transaction is a related par
HCG Approves FY26 Results, BACC Divestment, Management Changes
Board approved audited standalone and consolidated financial results for Q4 and year ended March 31, 2026, with unmodified audit opinion from B S R & Co. LLP.
Approved divestment of entire equity in B
HCG Launches 132-Bed Cancer Hospital in Hebbal
HealthCare Global Enterprises Limited launched a new 132-bed comprehensive cancer hospital in Hebbal, North Bengaluru on May 19, 2026.
The facility introduces Karnataka's first Elekta Unity MR-Linac,